Brief: Virpax Pharmaceuticals Announces Closing Of $5.0 Million Public Offering Of Common Stock And Pre-Funded Warrants
15/11/2024 21:58
Nov 15 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS, INC. ANNOUNCES CLOSING OF $5.0
MILLION
PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
Source text: ID:nBw51JRCxa
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study